← Open Payments lookup

LISA RUSSELL: Open Payments

NPI 1093472953 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,225 in 174 payments from 20 companies in 2025. Trend: 2023 $2,751 · 2024 $2,960 · 2025 $3,225

Food & beverage: $3,115Education: $109
CompanyPaymentsAmount
ABBVIE INC.30$559
Teva Pharmaceuticals USA, Inc.25$457
Alkermes, Inc.22$394
Vanda Pharmaceuticals Inc.18$370
Otsuka America Pharmaceutical, Inc.17$281
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$188
Neurocrine BioSciences, Inc.8$169
Axsome Therapeutics, Inc.8$145
Sage Therapeutics, LLC4$94
Takeda Pharmaceuticals U.S.A., Inc.6$93

Products named: VRAYLAR, FANAPT, REXULTI, AUSTEDO XR, ARISTADA, CAPLYTA, INGREZZA, LYBALVI.

Industry payments across PA — which companies pay providers there.